Dietary habits in people with inclusion body myositis
Part of Bones, joints & muscles, Brain & nervous system clinical trials.
This study looks at the diet and nutrition habits of people with inclusion body myositis (IBM) compared to healthy adults of similar age and activity level. It aims to understand how diet might affect the disease and inform better care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of inclusion body myositis (IBM) by a doctor.
- You must be at least 40 years old.
- You should be able to walk short distances, with or without a cane or walker, and be safe to do study tasks.
- You must be able to eat solid or softened food by mouth (not be fed only through a tube).
- You should not have other muscle, nerve, or metabolic diseases that could affect the study results.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses imaging to look at the muscles involved in swallowing and speaking in people with certain muscle diseases, like inclusion body myositis or ALS. The goal is to better understand these conditions, which might help improve care in the future.
This study asks people with autoimmune muscle diseases (myositis) and their caregivers to share their experiences and insights. By joining, you help shape better research and care for myositis.
This research study helps doctors better understand myositis—a group of rare diseases that cause muscle inflammation and weakness. Researchers collect blood samples, medical history, and sometimes muscle biopsies to learn more about what causes these conditions and how to treat them better.
This study looks at how obesity affects certain cell processes in muscle. It may help find new ways to treat or prevent muscle problems related to obesity.
This trial tests the drug ruxolitinib (a JAK inhibitor) for people with inclusion body myositis (IBM), a progressive muscle disease. It aims to see if ruxolitinib can help slow muscle weakness and improve function.
This study looks at body composition (fat and muscle) in people with Crohn's disease or ulcerative colitis. It tests if a new way to monitor body changes can help guide treatment with biologic or JAK inhibitor medicines.
Hear when a new Inclusion Body Myositis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.